ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Merrimack to reduce workforce by 60 percent as ends development of cancer drug MM-121
November 09, 2018Merrimack Pharmaceuticals announced plans to initiate a corporate restructuring that will see the drugmaker reduce expenses and slash its workforce by approximately... -
Merrimack Pharmaceuticals Expands Phase II Lung Cancer Study
March 13, 2018Merrimack Pharmaceuticals Inc. saw a slight uptick in pre-market trading this morning after the company announced it is expanding enrollment in a Phase II lung cancer study. -
Merrimack Appoints Head of Research
April 18, 2017Daryl Drummond, Ph.D. has been appointed head of research at Merrimack Pharmaceuticals. Dr. Drummond has expertise in the field of nanotherapeutics and has held various leadership roles at Merrimack -
Merrimack initiates Phase 1 study of MM-310 in solid tumours
March 30, 2017Merrimack Pharmaceuticals have enrolled its first patient in a Phase 1 study of MM-310 in solid tumours.
Pharma Sources Insight January 2025
